Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.2K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.5K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.5K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

975
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
975
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

570
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
570
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

580
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
580

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Report: Allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia and hepatitis E.

Frontiers in oncology·2026
Same author

Gender differences and psychosocial stress in upper respiratory tract infections: insights from healthy and hematological cancer cohorts.

BMC public health·2026
Same author

Management of infections in the outpatient care of patients with cancer.

Cancer treatment reviews·2026
Same author

Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology.

The Lancet. Oncology·2026
Same author

Challenges and Potential Solutions to Advance Global Cancer Drug Development.

Therapeutic innovation & regulatory science·2026
Same author

Seasonal community-acquired respiratory virus infections in patients with cancer-Epidemiological and clinical overview, an analysis of the multicenter OncoReVir registry.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Related Experiment Video

Updated: Feb 11, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

911

Challenges in Infectious Diseases for Haematologists.

Marie von Lilienfeld-Toal, Georg Maschmeyer

    Oncology Research and Treatment
    |May 8, 2018
    PubMed
    Summary

    Hematological malignancy patients face significant infection risks. This review addresses key challenges in infectious diseases, including bacterial infections, viral threats, and vaccination strategies for these vulnerable individuals.

    Keywords:
    Community acquired respiratory virusHaematological malignanciesInfectionsMulti-drug resistanceRe-activationTargeted therapiesVaccination

    More Related Videos

    Biocontained Carcass Composting for Control of Infectious Disease Outbreak in Livestock
    14:34

    Biocontained Carcass Composting for Control of Infectious Disease Outbreak in Livestock

    Published on: May 6, 2010

    11.3K
    In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
    12:23

    In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

    Published on: September 7, 2022

    2.1K

    Related Experiment Videos

    Last Updated: Feb 11, 2026

    Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
    03:22

    Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

    Published on: March 1, 2024

    911
    Biocontained Carcass Composting for Control of Infectious Disease Outbreak in Livestock
    14:34

    Biocontained Carcass Composting for Control of Infectious Disease Outbreak in Livestock

    Published on: May 6, 2010

    11.3K
    In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses
    12:23

    In Vitro Selection of Aptamers to Differentiate Infectious from Non-Infectious Viruses

    Published on: September 7, 2022

    2.1K

    Area of Science:

    • Hematology
    • Infectious Diseases
    • Oncology

    Background:

    • Infections pose a substantial threat to patients undergoing treatment for hematological malignancies.
    • Current clinical practice requires updated guidance on managing infectious diseases in this patient population.

    Purpose of the Study:

    • To provide a concise overview of the most relevant current challenges in infectious diseases for hematologists.
    • To summarize essential information for clinicians caring for patients with hematological malignancies.

    Main Methods:

    • Review of current challenges in infectious diseases based on the European Hematology Association roadmap.
    • Consolidation of recommendations from the Infectious Diseases Working Party of the German Society of Haematology and Medical Oncology guidelines.

    Main Results:

    • Key challenges include bacterial infections and antibiotic stewardship.
    • Other critical areas are community-acquired respiratory viruses, infections during targeted therapies, latent infection reactivation, and vaccination strategies.

    Conclusions:

    • Clinicians need updated information on managing diverse infections in hematology patients.
    • Adherence to evidence-based guidelines is crucial for optimizing patient outcomes and infection prevention.